Travere Therapeutics Inc (NASDAQ:TVTX)
| 29.06 BATS BZX Real-Time Price As of 1:32pm ET |  -0.06 / -0.21%Today’s Change | 12.75 Today|||52-Week Range 33.09 | +6.62% Year-to-Date |
Latest TVTX News | Press Releases
No recent news for Travere Therapeutics Inc.
Today’s Trading
| Previous close | 29.12 |
| Today’s open | 29.72 |
| Day’s range | 28.56 - 30.17 |
| Volume | 14,417 |
| Average volume (3 months) | 1,007,282 |
| Market cap | $1.8B |
Data as of 1:32pm ET, 11/29/2021
Growth & Valuation
| Earnings growth (last year) | -3.05% |
| Earnings growth (this year) | +22.26% |
| Earnings growth (next 5 years) | +137.00% |
| Revenue growth (last year) | +13.11% |
| P/E ratio | NM |
| Price/Sales | 6.53 |
| Price/Book | 7.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MYOVMyovant Sciences Ltd | +0.03 | +0.16% |
| ---- | ||
| MORFMorphic Holding Inc | -0.10 | -0.20% |
| SRNESorrento Therapeutic... | +0.08 | +1.34% |
Data as of 1:32pm ET, 11/29/2021
Financials
| Next reporting date | March 1, 2022 |
| EPS forecast (this quarter) | -$0.68 |
| Annual revenue (last year) | $198.3M |
| Annual profit (last year) | -$169.4M |
| Net profit margin | -85.43% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
